Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2010; 20(03): 192-194
DOI: 10.4103/0971-3026.69354
Neuroradiology

Diffusion-weighted magnetic resonance imaging in acute reversible toxic leukoencephalopathy: A report of two cases

S Sivasubramanian
Department of Radiology, Amrita Institute of Medical Sciences, Elamakkara, Cochin - 682 041, India
,
Srikant Moorthy
Department of Radiology, Amrita Institute of Medical Sciences, Elamakkara, Cochin - 682 041, India
,
KP Sreekumar
Department of Radiology, Amrita Institute of Medical Sciences, Elamakkara, Cochin - 682 041, India
,
R Rajesh Kannan
Department of Radiology, Amrita Institute of Medical Sciences, Elamakkara, Cochin - 682 041, India
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

Acute toxic leukoencephalopathy may be caused by endogenous or exogenous toxins. It may reverse clinically if the offending agent is withdrawn or the underlying condition is treated. However, demonstration of reversibility on imaging, especially with diffusion-weighted MRI, has been reported only very recently. We report two such cases.

Keywords

5-FU - diffusion restriction - leukoencephalopathy - uremia


Publication History

Article published online:
02 August 2021

© 2010. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001;345:425-32.
  • 2 McKinney AM, Kieffer SA, Paylor RT, SantaCruz KS, Kendi A, Lucato L. Acute toxic leukoencephalopathy: Potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR Am J Roentgenol 2009;193:192-206.
  • 3 Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
  • 4 Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: Utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000;21:1199-206.
  • 5 McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, et al. Posterior reversible encephalopathy syndrome: Incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904-12.
  • 6 Yerdelen D, Karatas M, Goksel BK, Yildirim T. Reversible Leukncephalopathy Syndrome Owing to Uremia with Anterior circulation Area lesions on MRI. Neurosurg Q 2008;18:294-6.
  • 7 Prόss H, Siebert E, Masuhr F. Reversible cytotoxic brain edema and facial weakness in uremic encephalopathy. J Neurology 2009;256:1372-3.
  • 8 Wu AN, Yin JH, Lo HC, Chang JL, Lee WH,. Leukoencephalopathy induced by chemotherapy with 5-fluorouracil: A case report. Acta Neurol Taiwan 2001;10:134-40.
  • 9 Lucato LT, McKinney AM, Short J, Teksam M, Truwit CL. Reversible findings of restricted diffusion in 5-Flourouracil Neurotoxicity. Australas Radiol 2006;50:364-8.